- Home
- GEVO
GEVO
Gevo Inc.
as 11-17-2025 3:45pm EST
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | ENGLEWOOD |
| Market Cap: | 498.2M | IPO Year: | 2011 |
| Target Price: | $8.13 | AVG Volume (30 days): | 4.3M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.92 - $2.98 | Next Earning Date: | 11-10-2025 |
| Revenue: | $120,932,000 | Revenue Growth: | 675.75% |
| Revenue Growth (this year): | 909.99% | Revenue Growth (next year): | 11.14% |
Stock Insider Trading Activity of Gevo Inc. (GEVO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Battershell Carol Jane | GEVO | Director | Nov 13 '25 | Sell | $2.02 | 75,597 | $152,781.54 | 278,265 | |
| Shafer Andrew | GEVO | Chief Cust Mkt & Brnd Officer | Nov 3 '25 | Sell | $2.28 | 29,797 | $67,969.94 | 285,823 | |
| Shafer Andrew | GEVO | Chief Cust Mkt & Brnd Officer | Oct 20 '25 | Sell | $2.53 | 5,000 | $12,650.00 | 285,823 | |
| Ryan Christopher Michael | GEVO | President & COO | Oct 15 '25 | Sell | $2.82 | 100,000 | $281,870.00 | 1,531,938 | |
| Amorelli Angelo | GEVO | Director | Oct 14 '25 | Sell | $2.50 | 100,000 | $250,270.00 | 2,942 | |
| Shafer Andrew | GEVO | Chief Cust Mkt & Brnd Officer | Sep 22 '25 | Sell | $2.01 | 5,000 | $10,062.00 | 285,823 | |
| Bloom Paul D | GEVO | Chief Business Officer | Sep 17 '25 | Sell | $2.01 | 75,000 | $150,435.00 | 923,591 | |
| Ryan Christopher Michael | GEVO | President & COO | Sep 4 '25 | Sell | $1.63 | 1,683 | $2,742.45 | 1,531,938 | |
| Bowron Kimberly T | GEVO | Chief People and IT Officer | Sep 4 '25 | Sell | $1.63 | 1,530 | $2,493.13 | 481,226 | |
| Gruber Patrick R. | GEVO | Chief Executive Officer | Sep 4 '25 | Sell | $1.63 | 1,642 | $2,675.64 | 3,845,462 |
Latest Gevo Inc. News
GEVO Breaking Stock News: Dive into GEVO Ticker-Specific Updates for Smart Investing
Simply Wall St.
21 hours ago
Institutions own 36% of Gevo, Inc. (NASDAQ:GEVO) shares but individual investors control 60% of the company
GuruFocus.com
7 days ago
Gevo Inc (GEVO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Positive EBITDA ...
Zacks
7 days ago
Gevo, Inc. (GEVO) Reports Q3 Loss, Lags Revenue Estimates
GlobeNewswire
7 days ago
Gevo Reports Third Quarter 2025 Financial Results
GlobeNewswire
13 days ago
Gevo North Dakota Sells Its Remaining 2025 45Z Production Tax Credits for $30 Million, Bringing the Contracted Total for the Year to $52 Million
GlobeNewswire
14 days ago
Gevo Completes Sale of Luverne, Minnesota, Ethanol Facility to A.E. Innovation, Retains Isobutanol Assets for Future Innovation
GlobeNewswire
15 days ago
Gevo Makes First Delivery of Certified Carbon Credits to Biorecro, Unlocking Value from Carbon as a Co-Product
GlobeNewswire
a month ago
Gevo to Report Third Quarter 2025 Financial Results on November 10, 2025
Compare GEVO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GEVO Gevo Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.